Bis((R)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)methane, 97%, 1g

5-Acetyl-2-(2,4-di-tert-butylphenoxy) pyridine, 95%, 1g

3-Bromo-4-iodobenzotrifluoride, 97.0%, 100g

Bicyclo[3.1.1]hept-3-en-2-one, 4,6,6-trimethyl-, (1S,5S)-, 97%, 25g

(2E,4E,6E,8E,10E)-4,9-Dimethyldodeca-2,4,6,8,10-pentaene-1,12-diol, 97%, 250mg

2-(2,3-Dioxo-2,3-dihydro-1h-indol-1-yl)-n-(3-methylphenyl)acetamide, 95%, 1g

5-(3-Nitro-phenyl)-[1,3,4]thiadiazol-2-ylamine, 95.0%, 5g

Quinoxyfen>98.0%(GC)200mg

2-[5-amino-3-(2-furyl)-1H-pyrazol-1-yl]-6-propylpyrimidin-4(3H)-one, 95.0%, 500mg

(2E)-3-[2-(ethylthio)pyrimidin-5-yl]acrylic acid, 95.0%, 5g

4-Bromopiperidine hydrobromide, 95.0%, 100g

2-Chloro-3-methoxy-5-nitropyridine, 95.0%, 5g

7-Methylindolin-2-one, 95.0%, 500mg